-
公开(公告)号：EP2404997A1
公开(公告)日：2012-01-11
申请号：EP10748842.1
申请日：2010-03-05
申请人： Mie University , TAKARA BIO INC.
IPC分类号： C12N15/00 , A61K35/14 , A61P31/00 , A61P35/00 , A61P37/06 , C12N5/10 , C12N15/09 , A61K31/713 , A61K48/00
CPC分类号： A61K35/17 , A61K2035/124 , A61K2039/5158 , C12N5/0636 , C12N15/113 , C12N2310/14 , C12N2501/48 , C12N2501/599 , C12N2310/531
摘要： Disclosed is a method for enhancing the function of a T cell, which is characterized by inhibiting the expression of programmed death-1 ligand 1 (PD-L1) and/or programmed death-1 ligand 2 (PD-L2) in the T cell. Also disclosed is a function-enhanced T cell which is produced by the function enhancement method. Further disclosed is a therapeutic agent comprising the function-enhanced T cell. The T cell can enhance an immune response to cancer, and is useful in an immunotherapy effective for cancer and the treatment or prevention of infectious diseases and autoimmune diseases.
-
公开(公告)号：EP2404997B1
公开(公告)日：2017-10-18
申请号：EP10748842.1
申请日：2010-03-05
申请人： Mie University , TAKARA BIO INC.
IPC分类号： C12N15/00 , A61K35/14 , A61P31/00 , A61P35/00 , A61P37/06 , C12N5/10 , C12N15/09 , A61K31/713 , A61K48/00 , C12N5/0783 , C12N15/113 , A61K35/12 , A61K35/17 , A61K39/00
CPC分类号： A61K35/17 , A61K2035/124 , A61K2039/5158 , C12N5/0636 , C12N15/113 , C12N2310/14 , C12N2501/48 , C12N2501/599 , C12N2310/531
摘要： Disclosed is a method for enhancing the function of a T cell, which is characterized by inhibiting the expression of programmed death-1 ligand 1 (PD-L1) and/or programmed death-1 ligand 2 (PD-L2) in the T cell. Also disclosed is a function-enhanced T cell which is produced by the function enhancement method. Further disclosed is a therapeutic agent comprising the function-enhanced T cell. The T cell can enhance an immune response to cancer, and is useful in an immunotherapy effective for cancer and the treatment or prevention of infectious diseases and autoimmune diseases.
-
搜索结果
2 条记录 (耗时 0.009 秒)
